Clinical Trial Update: D-cycloserine and Treatment of Feeding Disorders [Phase 1, Phase 2]

View source ↗

Summary

Phase 1 and Phase 2 trials evaluated D-cycloserine for feeding disorders and specific phobia. Results were posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Feeding Disorders
• Specific Phobia

Drugs mentioned

• D-cycloserine (D-cycloserine)

Snippet

Sponsor: Emory University | Conditions: Feeding Disorders, Specific Phobia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-10-23